Danaher to buy Masimo in $9.9 billion deal in diagnostics push

The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.

17 Feb, 13:15 — 17 Feb, 14:36

Post Share

Why this matters

This acquisition signifies Danaher's strategic expansion in the diagnostics sector, a critical area in healthcare. Such large-scale mergers can impact market competition, product innovation, and the availability of medical technologies.

Key entitiesDanaher Masimo

The Story

What 3 sources agree on, dispute, and miss

What sources agree on

Danaher will acquire Masimo
The deal is valued at approximately $9.9 billion
The acquisition is an all-cash transaction

Key claims1 agreed · 3 unverified

Danaher will pay $180 per share for Masimo

unverified·cnbc

The offer represents a 38.3% premium to Masimo's last close

unverified·cnbc

✓

The deal is valued at $9.9 billion

agreed·Yahoocnbc

The deal is valued at $10 billion

unverified·wsj

Coverage gaps

The per-share price Danaher will pay for Masimo

Reportedcnbc

MissingYahoowsj

The premium offered over Masimo's last closing price

Reportedcnbc

MissingYahoowsj

The Story

Analyzing sources…

Source Diversity

Moderate (37/100)

3 sources25/33

Spectrum spread— 2/5 buckets covered8/33

Far L

Left2

Left (2)

Yahoocnbc

Center

Right1

Right (1)

wsj

Far R

Geographic diversity— 1 region4/34

US3

ℹAll sources from US region

Sources

Showing 3 of 3 sources

wsjHigh173d ago

Danaher Strikes $10 Billion Deal for Masimo - The Wall Street Journal

Danaher Strikes $10 Billion Deal for Masimo The Wall Street Journal

Read full article →

cnbcMostly Factual173d ago